Itau Unibanco Holding S.A. Supernus Pharmaceuticals, Inc. Transaction History

Itau Unibanco Holding S.A.

  • $2.95 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020
SELL
$14.45 - $24.69 $41,818 - $71,452
-2,894 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$19.93 - $29.13 $57,677 - $84,302
2,894 New
2,894 $69,000
Q4 2018

Feb 13, 2019
SELL
$30.84 - $49.51 $69,420 - $111,447
-2,251 Closed
0 $0
Q3 2018

Nov 13, 2018
BUY
$42.7 - $56.55 $96,117 - $127,294
2,251 New
2,251 $113,000

Others Institutions Holding SUPN

# of Institutions
281
Shares Held
60.6M
Call Options Held
27.7K
Put Options Held
11.3K
View Full List

About SUPERNUS PHARMACEUTICALS, INC.

SUPN Quotes by TradingView
  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $1.98B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Itau Unibanco Holding S.A. Portfolio

Follow Itau Unibanco Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Itau Unibanco Holding S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email